Paychex Inc: Form 10-Q for the period ended Aug 31, 2023
Filed with the SEC on Sep 28, 2023 and accepted by EDGAR at Sep 28, 2023, 16:07 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2023-08-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2023-06-01 to 2023-08-31 | $1.25bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2023-06-01 to 2023-08-31 | $360.2m | us-gaap:CostOfRevenue |
| Selling, general and administrative | 3 months2023-06-01 to 2023-08-31 | $389.5m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2023-06-01 to 2023-08-31 | $536.3m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2023-06-01 to 2023-08-31 | $9.4m | us-gaap:InterestExpense |
| Income tax | 3 months2023-06-01 to 2023-08-31 | $129.9m | us-gaap:IncomeTaxExpenseBenefit |
| Diluted EPS | 3 months2023-06-01 to 2023-08-31 | $1.16 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2023-06-01 to 2023-08-31 | $1.16 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2023-06-01 to 2023-08-31 | 362,800,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months2023-06-01 to 2023-08-31 | $655.8m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months2023-06-01 to 2023-08-31 | $38.7m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 3 months2023-06-01 to 2023-08-31 | $321.9m | us-gaap:PaymentsOfDividendsCommonStock |
| Cash and equivalents | At period end2023-08-31 | $1.65bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2023-08-31 | $9.09bn | us-gaap:AssetsCurrent |
| Total assets | At period end2023-08-31 | $12.20bn | us-gaap:Assets |
| Current liabilities | At period end2023-08-31 | $7.34bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2023-08-31 | $8.61bn | us-gaap:Liabilities |
| Long-term debt | At period end2023-08-31 | $798.3m | us-gaap:LongTermDebtNoncurrent |
| Short-term borrowings | At period end2023-08-31 | $13.7m | us-gaap:ShortTermBorrowings |
| Shareholders' equity | At period end2023-08-31 | $3.59bn | us-gaap:StockholdersEquity |
| Shares outstanding | At period end2023-08-31 | 361,232,387 shares | dei:EntityCommonStockSharesOutstanding |
Source: SEC EDGAR, the filing index for accession 0000950170-23-050438. Last ingested by Listed: Oct 27, 2026, 16:32 ET. Listed shows no prices and gives no investment advice.